<h4>Purpose</h4>The relationship between mutant KRAS and the risk of disease progression and death in advanced non-squamous non-small cell lung cancer (NSCLC) is still controversial among current studies, and the effects of distinct KRAS mutations on prognosis may be different. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.